Parkinson's Disease Clinical Trials in San Antonio

Showing 101-120 of 132 trials

Single Ascending Dose Study of PRX002 in Healthy Subjects

NCT02095171

This single ascending dose study is to determine safety, tolerability, pharmacokinetics and immunogenicity of PRX002 in approximately 40 healthy subjects.

Parkinson's Disease

Prothena Biosciences Limited40 participantsStarted Mar 2014

San Antonio, Texas, United States

COMPLETEDPhase 3< 1 mile

Trial to Assess Parkinson's Disease (PD) Symptom Control to Four Doses of Rotigotine in a Transdermal Patch

NCT00522379

The purpose of this study is to show Rotigotine dose response at four doses of Rotigotine used with L-dopa in treating advanced stage Parkinson's disease.

Parkinson's Disease

UCB Pharma514 participantsStarted Jul 2007

Birmingham, Alabama, United States • Tuscaloosa, Alabama, United States • Gilbert, Arizona, United States +74 more locations

Single Ascending Dose Study of PRX002 in Healthy Subjects

Trial to Assess Parkinson's Disease (PD) Symptom Control to Four Doses of Rotigotine in a Transdermal Patch

Parkinson's Disease Trials in Other Cities

An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease.

A Fourteen-Week Placebo-Controlled Dose-Response Efficacy and Safety Study of NS 2330 in Early Parkinson's Disease Patients (Study for Proof of Concept in Early Parkinson's Disease of a Triple Reuptake Inhibitor, NS 2330 / SCEPTRE)

Safety of Urate Elevation in Parkinson's Disease

NET-PD LS-1 Creatine in Parkinson's Disease

Phase II Subthalamic Nucleus (STN) vs. Globus Pallidus (GPi) Trial

Study of (Mirapex) Pramipexole for the Early Treatment of Parkinsons Disease (PD)

Phase I Deep Brain Stimulation (DBS) vs. Best Medical Therapy (BMT) Trial

Ophthalmologic Safety Study of Pramipexole Immediate Release (IR) Versus Ropinirole in Early Parkinson's Disease (PD) Patients

Impulse Control Disorders in Parkinson's Patients Treated With Pramipexole and Other Agents (DOMINION Study)

MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist

Safinamide in Idiopathic Parkinson's Disease (IPD) With Motor Fluctuations, as add-on to Levodopa

A Study of E2007 In Patients With Parkinson's Disease

Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain

Safety, Tolerability and Efficacy Assessment of Dynacirc CR in Parkinson Disease

Long-term Safety Study of Open-label Pramipexole Extended Release (ER) in Patients With Early Parkinson´s Disease (PD).

PROGENI (Parkinson's Research: The Organized Genetics Initiative) Family Study of LRRK2 (Leucine-rich Repeat Kinase 2)

A Study to Assess Safety and Tolerability of Oral AZD3241 in Patients With Parkinson's Disease

Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects

Other Conditions in San Antonio